Cu-MOF-based targeted nanomedicine utilizing biorthogonally catalyzed chemotherapy and chemodynamic therapy with spatiotemporal orchestration to treat hepatocellular carcinoma
A nanomedicine was developed using a Cu-based metal-organic framework (MOF) to co-deliver Cu(I) and prodrugs for targeted biorthogonally catalyzed chemotherapy and chemodynamic therapy of hepatocellular carcinoma.
Authors
- Xiuyan Wan (ORCID: https://orcid.org/0000-0003-2785-9782)
- Wei Pan (ORCID: https://orcid.org/0000-0002-2281-8749)
- Na Li (ORCID: https://orcid.org/0000-0002-0392-6672)
- Yu Zhang (ORCID: https://orcid.org/0000-0001-7159-4561)
- Bo Tang (ORCID: https://orcid.org/0000-0002-8712-7025)
- Huiwen Zhang (ORCID: https://orcid.org/0000-0002-8241-325X)
- X. K. Qiao
Institutions
- Shandong Normal University (CN)
- Ministry of Education (ME)
- Laoshan Laboratory
Publication Details
- Journal
- Chemical Communications
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1039/d4cc05890a
- Citations
- 2
- Primary Topic
- Metal-Organic Frameworks: Synthesis and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.32